Acronyms

ACOSOG American College of Surgeons Oncology Group
ACRIN American College of Radiology Imaging Network
AE adverse event
ALChEMIST Adjuvant Lung Cancer Enrichment Marker Identification in Sequencing Trial
ALK anaplastic lymphoma kinase
AML acute myeloid leukemia
ASCO American Society of Clinical Oncology
 
BIQSFP Biomarker, Imaging, and Quality of Life Studies Funding Program
BRAF human homolog B of v-raf (Rapidly Accelerated Fibrosarcoma viral oncogene)
 
CALGB Cancer and Leukemia Group B
CCOP Community Clinical Oncology Program
CDER Center for Drug Evaluation and Research
CDMS Common IT Data Management System
CIRB Central Institutional Review Board
CLIA Clinical Laboratory Improvement Amendments
CMS Centers for Medicare & Medicaid Services
CRADA Cooperative Research and Development Agreement


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 79
Acronyms ACOSOG American College of Surgeons Oncology Group ACRIN American College of Radiology Imaging Network AE adverse event ALChEMIST Adjuvant Lung Cancer Enrichment Marker Identification in Sequencing Trial ALK anaplastic lymphoma kinase AML acute myeloid leukemia ASCO American Society of Clinical Oncology BIQSFP Biomarker, Imaging, and Quality of Life Studies Funding Program BRAF human homolog B of v-raf (Rapidly Accelerated Fibrosarcoma viral oncogene) CALGB Cancer and Leukemia Group B CCOP Community Clinical Oncology Program CDER Center for Drug Evaluation and Research CDMS Common IT Data Management System CIRB Central Institutional Review Board CLIA Clinical Laboratory Improvement Amendments CMS Centers for Medicare & Medicaid Services CRADA Cooperative Research and Development Agreement 79

OCR for page 79
80 IMPLEMENTING A NATIONAL CANCER CLINICAL TRIALS SYSTEM CRUK Cancer Research UK CSG Clinical Studies Group (in the UK) CT computed tomography CTAC Clinical Trials and Translational Research Advisory Group CTEP Cancer Therapy Evaluation Program CTU Clinical Trials Unit (in the UK) DNA deoxyribonucleic acid ECOG Eastern Cooperative Oncology Group EGFR epidermal growth factor receptor EMA European Medicines Agency FDA Food and Drug Administration FLT3 fms-like tyrosine kinase 3 (fms is the receptor for macrophage colony stimulating factor) GOG Gynecologic Oncology Group HER2 human epidermal growth factor receptor 2 IDE Investigational Device Exemption IND Investigational New Drug IOM Institute of Medicine IP intellectual property IRB institutional review board IRF independent radiology facility IT information technology KRAS Kirsten rat sarcoma oncogene NCCCP NCI Community Cancer Centers Program NCCTG North Central Cancer Treatment Group NCI National Cancer Institute NCORP NCI Community Oncology Research Program NCPF National Cancer Policy Forum NCRI National Cancer Research Institute (in the UK) NCRN National Cancer Research Network (in the UK)

OCR for page 79
ACRONYMS 81 NCTN National Clinical Trial Network NEWDIGS New Drug Development Paradigms NGS next-generation sequencing NHS National Health Service NIH National Institutes of Health NIHR National Institute of Health Research (in the UK) OEWG Operational Efficiency Working Group PET positron emission tomography PFS progression-free survival PTEN phosphatase and tensin homolog RATIFY Randomized AML Trial In FLT3 in <60 Year olds RFA request for application RTOG Radiation Therapy Oncology Group SEMATECH Semiconductor Manufacturing Technology SOP standard operating procedure SSC Scientific Steering Committee START Standard Terms of Agreement for Research Trials

OCR for page 79